Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS J.P. Morgan USD EM Diversified Bond 1-5 UCITS ETF USD dis
LU1645385839 · LU1645385839 · USD · domicile Luxembourg
Bonds · Government USD · 1-5 years · Emerging marketsSFDR art. 6
Index tracked: J.P. Morgan USD EM Diversified 3% capped 1-5 Year Bond Index
- TER
- 0.35%+ trans. 0.07%
- Fund size
- 37 m EUR
- Tracking difference
- −0.35%3-year avg
- 🇮🇹 tax rate
- 22.02%white list 29.47%
- Replication
- Physical (mixed: optimised/sampled)
- Income
- Distributingsemi-annual
- Duration
- 2.53 yrsshort (≤3 years)
Launch 31 Oct 2017 · costs from the KID as of 2 Sept 2026 · 4 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and will take proportionate exposure on the components of the J.P. Morgan USD EM Diversified 3% capped 1-5 Year Bond Index (Total Return) using a stratified approach (stratified sampling strategy) by investing in a representative sample of components of the underlying index selected by the portfolio manager using a 'portfolio optimisation' technique. The proportionate exposure by the Fund to the component securities will be substantially achieved either through direct investment or through the use of derivatives or through a…
Performance since series start (in euro) — base 100
31 Oct 2017 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +6.3% |
| 3 years | +17.1% |
| 5 years | +18.7% |
| 10 years | series too young |
| Since series start | +30.5% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 4.21% | 4.49% | 4.63% |
| Max drawdown | −3.85% | −3.91% | −19.64% |
| Sharpe | -0.52 | -0.17 | -1.01 |
| Sortino | -0.56 | -0.18 | -1.10 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU1645385839 · LU16453858391
RebalixLU1645385839 · LU1645385839 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +9.87% | +10.25% | −0.38% |
| 2024 | +7.68% | +7.83% | −0.14% |
| 2023 | +7.98% | +8.52% | −0.53% |
| 2022 | −10.05% | −10.58% | +0.53% |
| 2021 | +0.17% | +0.79% | −0.61% |
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 0.616 USD (5.66% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.616 | — |
| 2025 | 2 | 0.6984 | +6.44% |
| 2024 | 2 | 0.5546 | +5.23% |
| 2023 | 2 | 0.5312 | +5.14% |
| 2022 | 2 | 0.4398 | +3.68% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
SHEMB · Borsa Italiana (ETFplus)
SEAA · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 8 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · www.ubs.com/2/e/files/lux_etf_pe.pdf
The live sheet, always up to date
rebalix.com/en/etf/LU1645385839
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1645385839
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU1645385839 · LU16453858392